Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
NNMT activity is known to increase as aging progresses or in response to certain lifestyle factors, often resulting in a decline in metabolic efficiency and a buildup of stubborn fat
The trial tested oral administration primarily, and no controlled study has tested subcutaneous injection in humans
The needle creates minor tissue trauma
Quick AOD-9604 Dosing Summary AOD-9604 is a growth hormone fragment peptide administered via subcutaneous injection, typically dosed at 250-500 mcg daily in a fasted state
High NNMT activity has also been linked to: Poor mitochondrial function Increased oxidative stress Accelerated fat storage Inhibiting this enzyme helps reverse those metabolic imbalances
Because a large number of comparisons were performed on the relative abundance data, main effect results from these analyses also underwent a BenjaminiHochberg false discovery rate (FDR) correction for multiple comparisons, and instances where a result was significant after this correction have been duly noted
